Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03339739
Other study ID # PROPRGFO_2013/004
Secondary ID
Status Completed
Phase N/A
First received October 31, 2017
Last updated November 7, 2017
Start date October 18, 2014
Est. completion date December 30, 2016

Study information

Verified date November 2017
Source Universidad Nacional Andres Bello
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The effectiveness of mandibular exercises as a treatment of muscular Orofacial Pain is yet unknown. This study hypothesized that training exercises can be an effective therapy improving pain perception.


Description:

Temporomandibular disorders (TMDs) represent heterogeneous musculoskeletal disorders, where most common presentation is mandibular muscle pain, which is also more common among female than men. Many interventions have been proposed for this pain control, regarding drugs, oral splints, relaxing exercises and self awareness but little is known about mandibular active contraction exercises. The aim of this study is to evaluate the effects of mandibular exercises in pain perception and sensitivity in women. A double blind randomized clinical trial will be conducted among fertile university student women with Oral Contraceptives (OC) use -to control hormonal influences-, with report of facial pain and myofascial pain diagnosis (RDC/TMD). They will be assessed in Visual analogue scale (VAS), sleep quality, Pressure Pain Threshold (PPT) and pressure pain tolerance (PPTol), and then allocated in one of the three interventions for 21 days: isometric mandibular active exercises over silicone bars; video-guided isotonic mandibular contractions over cloth pegs or counseling about disorders nature as passive comparison. After 21 days, VAS, PPT and PPTol in bilateral temporalis and masseter muscles will be assessed for a second time,) and compared with initial pain status.

Data will be entered by single blind operator, and will be open for quality auditing. Site monitoring will be performed by the University clinical entities.

Data checks will be also performed as planned. Descriptive and analytical statistics will be performed to address the primary and secondary objectives.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date December 30, 2016
Est. primary completion date December 6, 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 26 Years
Eligibility Inclusion Criteria:

- Temporomandibular Myofascial pain diagnosis

- Oral contraceptives consumption

- Facial pain for at least 3 months (and at least 10 of the last 30 days at Visit 0)

- Agrees to terms for continuing/discontinuing certain prescription/over-the-counter pain medications.

Exclusion Criteria:

- Other orofacial pain diagnosis

- Oral surgery within 6 months

- Treatment for pain management within past 30 days

- Neurological or psychiatric disorders

- Orthodontic treatment

- History of pregnancy, pregnancy or breastfeeding.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Isometric mandibular exercises
daily video guided three-minutes routine in 21 days (days of OC consumption) of soft clenching over three millimeters silicone bars bilaterally on molars
Isotonic mandibular exercises
daily video guided three-minutes routine in 21 days (days of OC consumption) of isotonic dynamic contraction over calibrated cloth pegs on central incisors
Behavioral:
Counseling group
subjects included in this group get an education brochure about the disorder and receive no further interventions

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Universidad Nacional Andres Bello

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the weekly mean subjective pain index after 21 days of treatment Weekly mean subjective pain computed as the arithmetic mean of daily pain subjective values (visual analog scale - VAS) in Visit 1and prior to each study visit. Daily pain index is computed as pain intensity (0-100 numeric rating scale where 0 = "no pain" and 100 = "the most intense pain imaginable") for the different muscular sites tested. Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)
Primary Change in the weekly mean pressure pain threshold (PPT) after 21 days of treatment Weekly mean pressure pain threshold is computed as the arithmetic mean of daily pressure pain threshold values for muscular sites in Visit 1and prior to each study visit. Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)
Primary Change in the weekly mean pressure pain tolerance (PPTol) after 21 days of treatment Weekly mean pressure pain tolerance is computed as the arithmetic mean of daily pressure pain tolerance values for muscular sites in Visit 1and prior to each study visit. Plot is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied per anatomical muscle site. Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)
Secondary Change in pressure pain threshold at temporalis muscle after 1 week of treatment Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)
Secondary Change in pressure pain threshold at temporalis muscle after 2 weeks of treatment Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. Visit 1 (study day 0) and Visit 2 (study day 14) ( 7 days in between)
Secondary Change in pressure pain threshold at temporalis muscle after 3 weeks of treatment Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. Visit 1 (study day 0) and Visit 2 (study day 21) ( 7 days in between)
Secondary Change in pressure pain threshold at masseter muscle after 1 week of treatment Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)
Secondary Change in pressure pain threshold at masseter muscle after 2 weeks of treatment Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between)
Secondary Change in pressure pain threshold at masseter muscle after 3 weeks of treatment Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of t masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between)
Secondary Change in pressure pain tolerance at temporalis muscle after 1 week of treatment Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle. Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)
Secondary Change in pressure pain tolerance at temporalis muscle after 2 weeks of treatment Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle. Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between)
Secondary Change in pressure pain tolerance at temporalis muscle after 3 weeks of treatment Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle. Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between)
Secondary Change in pressure pain tolerance at masseter muscle after 1 week of treatment Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of masseter muscle. Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)
Secondary Change in pressure pain tolerance at masseter muscle after 2 weeks of treatment Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of masseter muscle. Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between)
Secondary Change in pressure pain tolerance at masseter muscle after 3 weeks of treatment Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of masseter muscle. Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between)
Secondary Change in the Pittsburgh Sleep Quality Index (PSQI) global score after 21 days of treatment The PSQI has 19 items grouped into 7 component scores, each weighted equally on a 0-3 scale. The 7 component scores are summed to obtain a global score, which has a range of 0-21. Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)
See also
  Status Clinical Trial Phase
Completed NCT02839967 - Influence of Intraoral Photobiomodulation in Individuals With Temporomandibular Joint Dysfunction N/A
Completed NCT01659840 - Efficacy of Red and Infrared Lasers in Treatment of Temporomandibular Disorders N/A
Recruiting NCT05720065 - Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A Phase 2
Recruiting NCT03029494 - Oxidative Stress and Opiorphin in Temporomandibular Disorders N/A
Recruiting NCT05607823 - Adding Core Stabilization Training to Manuel Therapy in Temporomandibular Disorders N/A
Completed NCT04948320 - Temporomandibular Dysfunction Affects Neck Disability, Headache, Anxiety, And Sleep Quality In Women: A Cross-Sectional Study
Recruiting NCT04726683 - Dry Needling vs Injection in Patients With Temporomandibular Disorders N/A
Completed NCT01201512 - CONDOR Temporomandibular Muscle and Joint Disorders (TMJD) Survey N/A
Completed NCT04098952 - Effects of Electric Massage on the Cervical Region in Subjects Diagnosed With Temporomandibular Disorders N/A
Terminated NCT05162027 - Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE) Phase 2
Completed NCT03926767 - Additional Effect of Pain Neuroscience Education to Orofacial and Neck Exercises in Temporomandibular Disorders N/A
Recruiting NCT05902026 - The BETY-Biopsychosocial Questionnaire (BETY-BQ) in Individuals With Temporomandibular Dysfunction-Related Headache
Completed NCT03736408 - Frequency of Occurrence of the Pain Form of Temporomandibular Joint Dysfunction
Recruiting NCT04694274 - Genetic Polymorphisms and Their Association With Temporomandibular Disorders
Recruiting NCT01544439 - Occlusal Splint and Counseling to Temporomandibular Disorder Phase 3
Completed NCT01535378 - Interest of Behavioural Reeducation in Dysfunctions of Masticatory Apparatus. Relations Between Parafunctions and Dysfunctions of Mastixatory Apparatus N/A
Completed NCT02380105 - Effectiveness of a Counseling Program for Temporomandibular Disorders (TMD) Treatment N/A
Completed NCT02230371 - Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles Phase 4
Recruiting NCT03990662 - What Are the Clinical Factors Associated With a Significant Pain Reduction Following Physiotherapy in Patients With Temporomandibular Disorders?
Recruiting NCT05927545 - Efficacy of Manuel Therapy and BETY in Patients With Temporomandibular Dysfunction Related Headache N/A